Wolverine Trading’s BioTelemetry, Inc. BEAT Stock Holding History

Wolverine Trading’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-9,095	Closed	-$655K	–	6658
2020 Q4	$655K	Buy	+9,095	New	+$476K	﹤0.01%	2854
2020 Q3	–	Sell	-4,905	Closed	-$218K	–	5506
2020 Q2	$218K	Buy	+4,905	New	+$220K	﹤0.01%	3729
2020 Q1	–	Sell	-19,951	Closed	-$926K	–	5722
2019 Q4	$926K	Buy	19,951 +9,314	+88%	+$403K	﹤0.01%	2485
2019 Q3	$431K	Buy	+10,637	New	+$459K	﹤0.01%	2789
2019 Q2	–	Sell	-14,688	Closed	-$772K	–	5532
2019 Q1	$920K	Buy	+14,688	New	+$1.01M	﹤0.01%	2161
2018 Q3	–	Sell	-21,281	Closed	-$661K	–	6521
2018 Q2	$661K	Hold	21,281	–	–	﹤0.01%	2727
2018 Q1	$661K	Buy	+21,281	New	+$700K	﹤0.01%	2727

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Wolverine Trading's BEAT Position: Q1 2021 in Review

Wolverine Trading sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 9,095 shares — an estimated $655K sold.

Wolverine Trading first reported a position in BEAT in Q1 2018 and held it in 7 quarters. The position peaked at $926K in Q4 2019. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Wolverine Trading reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Wolverine Trading sold 9,095 BioTelemetry, Inc. shares in Q1 2021, an estimated $655K.
Wolverine Trading first reported a position in BioTelemetry, Inc. in Q1 2018 and held it in 7 quarters.
Wolverine Trading's BioTelemetry, Inc. position peaked at $926K in Q4 2019.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Wolverine Trading's 13F filing for Q1 2021, filed 14 May 2021.